| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/12/2001 | EP1131443A2 Human hydrolase proteins |
| 09/12/2001 | EP1131436A1 Urotensins ii of mammals and their uses |
| 09/12/2001 | EP1131434A2 Apoptosis-inducing factor |
| 09/12/2001 | EP1131431A2 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model |
| 09/12/2001 | EP1131430A2 Mitogenic regulators |
| 09/12/2001 | EP1131429A1 Calcium binding protein |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131426A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 09/12/2001 | EP1131425A2 Inflammation-associated genes |
| 09/12/2001 | EP1131422A1 Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof |
| 09/12/2001 | EP1131417A2 Engineered cytotoxic ribonuclease |
| 09/12/2001 | EP1131406A2 Low oxygen culturing of central nervous system progenitor cells |
| 09/12/2001 | EP1131357A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 09/12/2001 | EP1131356A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 09/12/2001 | EP1131354A1 Contraceptive antibody vaccines |
| 09/12/2001 | EP1131353A1 Intracellular c-terminal hdl-receptor domain |
| 09/12/2001 | EP1131352A2 Rantes-derived peptides with anti-hiv activity |
| 09/12/2001 | EP1131351A2 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 09/12/2001 | EP1131350A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 09/12/2001 | EP1131349A2 Potassium channel interactors and uses therefor |
| 09/12/2001 | EP1131348A1 Regulatory/unfolding peptides of ezrin |
| 09/12/2001 | EP1131347A2 Product |
| 09/12/2001 | EP1131344A2 Retro-inversion peptides that target git transport receptors and related methods |
| 09/12/2001 | EP1131343A1 Hydrophilic somatostatin analogs |
| 09/12/2001 | EP1131342A1 Compositions and methods for controlling plant pests |
| 09/12/2001 | EP1131341A1 Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, it's selection, pharmaceuticial compositions and use |
| 09/12/2001 | EP1131340A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 09/12/2001 | EP1131338A1 Method for the production of purified invasin protein and use thereof |
| 09/12/2001 | EP1131332A1 Antisense modulation of inhibitor-kappa b kinase-beta expression |
| 09/12/2001 | EP1131326A1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 09/12/2001 | EP1131317A1 Method for preparing (2s)-1- (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl] pyrrolidine-2- carboxamide |
| 09/12/2001 | EP1131113A1 Bioactive prostheses with immunosuppressive, antistenotic and antithrombotic properties |
| 09/12/2001 | EP1131107A1 Antisense modulation of inhibitor-kappa b kinase-alpha expression |
| 09/12/2001 | EP1131106A1 Compositions and methods for producing vascular occlusion |
| 09/12/2001 | EP1131097A1 Anti-icam-r antibody-induced apoptosis |
| 09/12/2001 | EP1131093A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-cd20 antibody |
| 09/12/2001 | EP1131091A1 Method of treating viral hemorrhagic fever |
| 09/12/2001 | EP1131090A2 Method of using pon-1 to decrease atheroma formation |
| 09/12/2001 | EP1131089A1 Stable aqueous insulin preparations without phenol and cresol |
| 09/12/2001 | EP1131088A2 NF-$g(k)B ACTIVATION INHIBITORS, AND THEIR PHARMACEUTICAL USES |
| 09/12/2001 | EP1131087A2 Methods of alleviating cancer symptoms |
| 09/12/2001 | EP1131086A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 09/12/2001 | EP1131085A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 09/12/2001 | EP1131084A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 09/12/2001 | EP1131083A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 09/12/2001 | EP1131082A2 A method for treating tissue damaged from ischemia |
| 09/12/2001 | EP1131081A1 Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway |
| 09/12/2001 | EP1131067A1 Composition and use of rar antagonists for promoting chondrogenesis |
| 09/12/2001 | EP1131059A1 Dry powder for inhalation |
| 09/12/2001 | EP1131056A1 Particles based on polyamino-acid(s) and methods for preparing same |
| 09/12/2001 | EP1131055A1 Treatment set containing lungsurfactant compositions |
| 09/12/2001 | EP1130979A1 Calcium fortified juice-based nutritional supplement |
| 09/12/2001 | EP1130969A1 Murf2 polypeptides and polynucleotides |
| 09/12/2001 | EP1130961A1 Stabilisation of milk from transgenic animals |
| 09/12/2001 | EP1049481A4 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 09/12/2001 | EP0991424B1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 09/12/2001 | EP0991423B1 Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 09/12/2001 | EP0960129A4 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF |
| 09/12/2001 | EP0929572A4 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 09/12/2001 | EP0886527B1 Pharmaceutical compositions comprising natural human alpha-interferon |
| 09/12/2001 | EP0833848B1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation |
| 09/12/2001 | EP0822826B1 Nitrosylated neuropeptides |
| 09/12/2001 | EP0808326B1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics |
| 09/12/2001 | EP0804452B1 Recombinant c140 receptor, its agonists and antagonists |
| 09/12/2001 | EP0789585B1 A storage stable water solution for infusion containing a thrombin inhibitor |
| 09/12/2001 | EP0766736B1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 09/12/2001 | EP0704056B1 Leukocyte adhesion assay |
| 09/12/2001 | EP0697885B1 Insulin-like growth factor ii as antitumour agent |
| 09/12/2001 | EP0687300B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 09/12/2001 | EP0637249B1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides |
| 09/12/2001 | EP0586474B1 Peptide nucleic acids |
| 09/12/2001 | EP0449856B1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 09/12/2001 | CN1312858A Bactericidal/permeability-increasing protein delation analogs |
| 09/12/2001 | CN1312856A Enzymatic nucleic acid treamtent of diseases or conditions related to hepatitisc virus infection |
| 09/12/2001 | CN1312817A Dolastatin 15 derivatives |
| 09/12/2001 | CN1312724A TNF-drvived peptides of use in treating oedema |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1312708A Process of generating submicron particles of water-insuluble compounds |
| 09/12/2001 | CN1312385A Human dihydroorotase 9 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312383A Human alpha-galactosidase A-11 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312382A Human RNA unwinding enzyme 9 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312381A Human cyclic AMP phosphodiesterase 13 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312380A Human unwinding enzyme 10 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312378A Human RNA unwinding enzyme 13 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312377A Human unwinding enzyme 69 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312376A Human NADH dehydrogenase 13 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312375A Human tyrosinase 12 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312370A Human ATP dependent serine proteinase 11 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312369A Human acceptor related protein tyrosine phosphatase 11 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312294A Human blood and blood vessel cytopoiesis hormone and its preparation |
| 09/12/2001 | CN1312293A Gene antibiotic peptide medicine prepared from transgenic antibiotic peptide fly maggot and its use |
| 09/12/2001 | CN1312292A Preparation process of gene antibiotic peptide medicine from transgenic antibiotic peptide fly maggot |
| 09/12/2001 | CN1312291A Human ribosome protein S4-19 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312290A Human ribosome SII protein 12 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312288A Human amyloid glucoprotein 9 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312287A Human zinc finger protein 13 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312284A Human CDC4 analogous protein 12 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312283A Human cytochrome constituting protein 14 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312282A Human actin 14 as one new polypeptide and polynucleotides encoding this polypeptide |